Thailand

Thailand

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
0.7 2006 Survey/reported Chongsrisawat V et al, 2006
1.36 (0.98 - 1.79) 2015 Modelled WHO
3.5 (1.60 - 4) 2016 Modelled Razavi-Shearer et al, 2018
6.42 (6.37 - 6.47) 2013 Modelled Schweitzer et al, 2015
4.75 (4.43 - 5.09) 2019 Modelled IHME, GBD 2019 (accessed 2020)
5.21 (4.86 - 5.54) 2018 Modelled IHME, GBD 2019 (accessed 2022)
5.28 (4.91 - 5.66) 2017 Modelled IHME, GBD 2019 (accessed 2022)
5.32 (4.96 - 5.65) 2016 Modelled IHME, GBD 2019 (accessed 2022)
5.36 (4.96 - 5.73) 2015 Modelled IHME, GBD 2019 (accessed 2022)
5.41 (5.04 - 5.77) 2014 Modelled IHME, GBD 2019 (accessed 2022)
5.49 (5.13 - 5.85) 2013 Modelled IHME, GBD 2019 (accessed 2022)
5.57 (5.23 - 5.94) 2012 Modelled IHME, GBD 2019 (accessed 2022)
5.64 (5.29 - 6.02) 2011 Modelled IHME, GBD 2019 (accessed 2022)
5.69 (5.31 - 6.07) 2010 Modelled IHME, GBD 2019 (accessed 2022)
5.73 (5.36 - 6.10) 2009 Modelled IHME, GBD 2019 (accessed 2022)
5.78 (5.41 - 6.15) 2008 Modelled IHME, GBD 2019 (accessed 2022)
5.86 (5.49 - 6.22) 2007 Modelled IHME, GBD 2019 (accessed 2022)
5.93 (5.55 - 6.32) 2006 Modelled IHME, GBD 2019 (accessed 2022)
5.99 (5.57 - 6.39) 2005 Modelled IHME, GBD 2019 (accessed 2022)
6.04 (5.64 - 6.43) 2004 Modelled IHME, GBD 2019 (accessed 2022)
6.11 (5.71 - 6.51) 2003 Modelled IHME, GBD 2019 (accessed 2022)
6.2 (5.77 - 6.61) 2002 Modelled IHME, GBD 2019 (accessed 2022)
6.29 (5.85 - 6.71) 2001 Modelled IHME, GBD 2019 (accessed 2022)
6.35 (5.90 - 6.80) 2000 Modelled IHME, GBD 2019 (accessed 2022)
6.43 (6 - 6.88) 1999 Modelled IHME, GBD 2019 (accessed 2022)
6.53 (6.10 - 7) 1998 Modelled IHME, GBD 2019 (accessed 2022)
6.64 (6.22 - 7.16) 1997 Modelled IHME, GBD 2019 (accessed 2022)
6.75 (6.31 - 7.30) 1996 Modelled IHME, GBD 2019 (accessed 2022)
6.84 (6.37 - 7.44) 1995 Modelled IHME, GBD 2019 (accessed 2022)
6.92 (6.45 - 7.53) 1994 Modelled IHME, GBD 2019 (accessed 2022)
7.01 (6.52 - 7.63) 1993 Modelled IHME, GBD 2019 (accessed 2022)
7.11 (6.60 - 7.75) 1992 Modelled IHME, GBD 2019 (accessed 2022)
7.2 (6.67 - 7.87) 1991 Modelled IHME, GBD 2019 (accessed 2022)
7.29 (6.72 - 7.99) 1990 Modelled IHME, GBD 2019 (accessed 2022)
5.08 (4.72 - 5.45) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.17 (0.10 - 0.26) 2015 Modelled WHO
0.36 (0.28 - 0.45) 2019 Modelled IHME, GBD 2019 (accessed 2020)
0.45 (0.36 - 0.56) 2019 Modelled IHME, GBD 2019 (accessed 2022)
0.48 (0.38 - 0.59) 2018 Modelled IHME, GBD 2019 (accessed 2022)
0.49 (0.39 - 0.61) 2017 Modelled IHME, GBD 2019 (accessed 2022)
0.5 (0.39 - 0.61) 2016 Modelled IHME, GBD 2019 (accessed 2022)
0.5 (0.39 - 0.63) 2015 Modelled IHME, GBD 2019 (accessed 2022)
0.52 (0.41 - 0.64) 2014 Modelled IHME, GBD 2019 (accessed 2022)
0.55 (0.43 - 0.68) 2013 Modelled IHME, GBD 2019 (accessed 2022)
0.58 (0.46 - 0.72) 2012 Modelled IHME, GBD 2019 (accessed 2022)
0.61 (0.49 - 0.75) 2011 Modelled IHME, GBD 2019 (accessed 2022)
0.62 (0.49 - 0.76) 2010 Modelled IHME, GBD 2019 (accessed 2022)
0.6 (0.48 - 0.74) 2009 Modelled IHME, GBD 2019 (accessed 2022)
0.57 (0.45 - 0.70) 2008 Modelled IHME, GBD 2019 (accessed 2022)
0.53 (0.42 - 0.66) 2007 Modelled IHME, GBD 2019 (accessed 2022)
0.5 (0.40 - 0.62) 2006 Modelled IHME, GBD 2019 (accessed 2022)
0.49 (0.38 - 0.61) 2005 Modelled IHME, GBD 2019 (accessed 2022)
0.49 (0.38 - 0.61) 2004 Modelled IHME, GBD 2019 (accessed 2022)
0.49 (0.39 - 0.61) 2003 Modelled IHME, GBD 2019 (accessed 2022)
0.49 (0.39 - 0.61) 2002 Modelled IHME, GBD 2019 (accessed 2022)
0.49 (0.39 - 0.62) 2001 Modelled IHME, GBD 2019 (accessed 2022)
0.5 (0.39 - 0.63) 2000 Modelled IHME, GBD 2019 (accessed 2022)
0.52 (0.41 - 0.67) 1999 Modelled IHME, GBD 2019 (accessed 2022)
0.59 (0.47 - 0.75) 1998 Modelled IHME, GBD 2019 (accessed 2022)
0.7 (0.55 - 0.87) 1997 Modelled IHME, GBD 2019 (accessed 2022)
0.83 (0.66 - 1.03) 1996 Modelled IHME, GBD 2019 (accessed 2022)
0.99 (0.79 - 1.22) 1995 Modelled IHME, GBD 2019 (accessed 2022)
1.25 (0.99 - 1.53) 1994 Modelled IHME, GBD 2019 (accessed 2022)
1.67 (1.33 - 2.05) 1993 Modelled IHME, GBD 2019 (accessed 2022)
2.21 (1.76 - 2.73) 1992 Modelled IHME, GBD 2019 (accessed 2022)
2.85 (2.28 - 3.52) 1991 Modelled IHME, GBD 2019 (accessed 2022)
3.54 (2.82 - 4.40) 1990 Modelled IHME, GBD 2019 (accessed 2022)
0.27 (0.23 - 0.32) 2020 Modelled WHO
Showing out of
Show more
Technical notes

Number of people living with chronic HBV

National
Download
Value Year Type Source
2,412,000 (1,126,000 - 2,784,000) 2016 Modelled Razavi-Shearer et al, 2018
3,333,110 (3,103,550 - 3,569,810) 2019 Modelled IHME, GBD 2019 (accessed 2020)
3,457,210 (3,215,560 - 3,703,000) 2019 Modelled IHME, GBD 2019 (accessed 2022)
3,535,080 (3,300,480 - 3,766,130) 2018 Modelled IHME, GBD 2019 (accessed 2022)
3,575,360 (3,321,030 - 3,829,270) 2017 Modelled IHME, GBD 2019 (accessed 2022)
3,587,760 (3,350,750 - 3,814,340) 2016 Modelled IHME, GBD 2019 (accessed 2022)
3,600,140 (3,338,030 - 3,848,460) 2015 Modelled IHME, GBD 2019 (accessed 2022)
3,620,860 (3,369,140 - 3,857,280) 2014 Modelled IHME, GBD 2019 (accessed 2022)
3,655,970 (3,418,090 - 3,893,000) 2013 Modelled IHME, GBD 2019 (accessed 2022)
3,691,750 (3,464,600 - 3,928,530) 2012 Modelled IHME, GBD 2019 (accessed 2022)
3,716,880 (3,474,480 - 3,959,580) 2011 Modelled IHME, GBD 2019 (accessed 2022)
3,723,220 (3,465,250 - 3,968,140) 2010 Modelled IHME, GBD 2019 (accessed 2022)
3,762,930 (3,521,510 - 4,000,700) 2009 Modelled IHME, GBD 2019 (accessed 2022)
3,856,180 (3,606,920 - 4,099,780) 2008 Modelled IHME, GBD 2019 (accessed 2022)
3,869,790 (3,622,880 - 4,105,900) 2007 Modelled IHME, GBD 2019 (accessed 2022)
3,793,700 (3,542,440 - 4,031,400) 2006 Modelled IHME, GBD 2019 (accessed 2022)
3,749,380 (3,487,770 - 4,000,460) 2005 Modelled IHME, GBD 2019 (accessed 2022)
3,755,200 (3,502,490 - 3,995,460) 2004 Modelled IHME, GBD 2019 (accessed 2022)
3,778,760 (3,525,800 - 4,022,780) 2003 Modelled IHME, GBD 2019 (accessed 2022)
3,810,100 (3,544,050 - 4,059,690) 2002 Modelled IHME, GBD 2019 (accessed 2022)
3,839,060 (3,567,610 - 4,096,780) 2001 Modelled IHME, GBD 2019 (accessed 2022)
3,855,890 (3,574,230 - 4,130,560) 2000 Modelled IHME, GBD 2019 (accessed 2022)
3,876,710 (3,608,570 - 4,155,270) 1999 Modelled IHME, GBD 2019 (accessed 2022)
3,914,320 (3,659,360 - 4,196,160) 1998 Modelled IHME, GBD 2019 (accessed 2022)
3,956,320 (3,702,240 - 4,256,060) 1997 Modelled IHME, GBD 2019 (accessed 2022)
3,991,920 (3,728,750 - 4,321,780) 1996 Modelled IHME, GBD 2019 (accessed 2022)
4,009,660 (3,731,750 - 4,354,570) 1995 Modelled IHME, GBD 2019 (accessed 2022)
4,017,540 (3,737,570 - 4,369,630) 1994 Modelled IHME, GBD 2019 (accessed 2022)
4,028,430 (3,750,060 - 4,386,330) 1993 Modelled IHME, GBD 2019 (accessed 2022)
4,037,300 (3,752,540 - 4,402,080) 1992 Modelled IHME, GBD 2019 (accessed 2022)
4,040,470 (3,741,370 - 4,414,000) 1991 Modelled IHME, GBD 2019 (accessed 2022)
4,036,580 (3,722,400 - 4,417,320) 1990 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
18.9 (13.20 - 26.10) 2019 Modelled IHME, GBD 2019 (accessed 2020)
12.28 (10.31 - 14.49) 1990 Modelled IHME, GBD 2019 (accessed 2022)
12.72 (10.73 - 14.99) 1991 Modelled IHME, GBD 2019 (accessed 2022)
13.02 (10.93 - 15.38) 1992 Modelled IHME, GBD 2019 (accessed 2022)
13.28 (11.19 - 15.85) 1993 Modelled IHME, GBD 2019 (accessed 2022)
13.59 (11.44 - 16.03) 1994 Modelled IHME, GBD 2019 (accessed 2022)
13.89 (11.49 - 16.57) 1995 Modelled IHME, GBD 2019 (accessed 2022)
13.44 (10.31 - 16.81) 1998 Modelled IHME, GBD 2019 (accessed 2022)
13.24 (10.36 - 16.44) 1997 Modelled IHME, GBD 2019 (accessed 2022)
14.1 (11.55 - 16.94) 1996 Modelled IHME, GBD 2019 (accessed 2022)
14.18 (11.45 - 17.16) 1999 Modelled IHME, GBD 2019 (accessed 2022)
14.16 (11.55 - 17.23) 2000 Modelled IHME, GBD 2019 (accessed 2022)
13.59 (10.80 - 16.88) 2001 Modelled IHME, GBD 2019 (accessed 2022)
13.75 (11.28 - 16.57) 2002 Modelled IHME, GBD 2019 (accessed 2022)
13.87 (11.14 - 16.73) 2004 Modelled IHME, GBD 2019 (accessed 2022)
13.79 (11.33 - 16.58) 2003 Modelled IHME, GBD 2019 (accessed 2022)
14.08 (11.26 - 17.22) 2005 Modelled IHME, GBD 2019 (accessed 2022)
14.33 (11.52 - 17.52) 2006 Modelled IHME, GBD 2019 (accessed 2022)
14.31 (11.55 - 17.46) 2007 Modelled IHME, GBD 2019 (accessed 2022)
14.55 (11.77 - 17.69) 2008 Modelled IHME, GBD 2019 (accessed 2022)
15.91 (12.63 - 19.46) 2010 Modelled IHME, GBD 2019 (accessed 2022)
15.16 (12.23 - 18.47) 2009 Modelled IHME, GBD 2019 (accessed 2022)
16.38 (13.19 - 20.07) 2011 Modelled IHME, GBD 2019 (accessed 2022)
16.68 (13.46 - 20.60) 2012 Modelled IHME, GBD 2019 (accessed 2022)
16.74 (13.45 - 20.45) 2013 Modelled IHME, GBD 2019 (accessed 2022)
17.24 (13.82 - 21.21) 2015 Modelled IHME, GBD 2019 (accessed 2022)
16.99 (13.55 - 20.81) 2014 Modelled IHME, GBD 2019 (accessed 2022)
17.83 (14.09 - 22.41) 2016 Modelled IHME, GBD 2019 (accessed 2022)
18.24 (13.51 - 23.66) 2017 Modelled IHME, GBD 2019 (accessed 2022)
18.54 (13.37 - 25.21) 2018 Modelled IHME, GBD 2019 (accessed 2022)
18.88 (13.18 - 26.15) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
16,512 2016 Modelled WHO
6,983 (5,863 - 8,241) 1990 Modelled IHME, GBD 2019 (accessed 2022)
7,331 (6,186 - 8,641) 1991 Modelled IHME, GBD 2019 (accessed 2022)
7,605 (6,384 - 8,980) 1992 Modelled IHME, GBD 2019 (accessed 2022)
7,844 (6,609 - 9,365) 1993 Modelled IHME, GBD 2019 (accessed 2022)
8,115 (6,829 - 9,571) 1994 Modelled IHME, GBD 2019 (accessed 2022)
8,375 (6,924 - 9,988) 1995 Modelled IHME, GBD 2019 (accessed 2022)
8,583 (7,031 - 10,306) 1996 Modelled IHME, GBD 2019 (accessed 2022)
8,125 (6,358 - 10,086) 1997 Modelled IHME, GBD 2019 (accessed 2022)
8,309 (6,377 - 10,395) 1998 Modelled IHME, GBD 2019 (accessed 2022)
8,831 (7,127 - 10,685) 1999 Modelled IHME, GBD 2019 (accessed 2022)
8,881 (7,241 - 10,804) 2000 Modelled IHME, GBD 2019 (accessed 2022)
8,584 (6,820 - 10,658) 2001 Modelled IHME, GBD 2019 (accessed 2022)
8,945 (7,189 - 10,795) 2004 Modelled IHME, GBD 2019 (accessed 2022)
8,747 (7,176 - 10,539) 2002 Modelled IHME, GBD 2019 (accessed 2022)
8,834 (7,257 - 10,620) 2003 Modelled IHME, GBD 2019 (accessed 2022)
9,147 (7,312 - 11,187) 2005 Modelled IHME, GBD 2019 (accessed 2022)
9,803 (7,914 - 11,959) 2007 Modelled IHME, GBD 2019 (accessed 2022)
9,497 (7,638 - 11,611) 2006 Modelled IHME, GBD 2019 (accessed 2022)
10,057 (8,133 - 12,222) 2008 Modelled IHME, GBD 2019 (accessed 2022)
10,309 (8,317 - 12,563) 2009 Modelled IHME, GBD 2019 (accessed 2022)
11,152 (8,977 - 13,666) 2011 Modelled IHME, GBD 2019 (accessed 2022)
10,769 (8,546 - 13,170) 2010 Modelled IHME, GBD 2019 (accessed 2022)
11,422 (9,218 - 14,105) 2012 Modelled IHME, GBD 2019 (accessed 2022)
11,520 (9,259 - 14,072) 2013 Modelled IHME, GBD 2019 (accessed 2022)
11,962 (9,589 - 14,720) 2015 Modelled IHME, GBD 2019 (accessed 2022)
11,741 (9,364 - 14,384) 2014 Modelled IHME, GBD 2019 (accessed 2022)
12,414 (9,814 - 15,605) 2016 Modelled IHME, GBD 2019 (accessed 2022)
12,977 (9,360 - 17,643) 2018 Modelled IHME, GBD 2019 (accessed 2022)
12,736 (9,430 - 16,524) 2017 Modelled IHME, GBD 2019 (accessed 2022)
13,240 (9,240 - 18,333) 2019 Modelled IHME, GBD 2019 (accessed 2022)
13,240 (9,240 - 18,333) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
131 (104 - 159) 1991 Modelled IHME, GBD 2019 (accessed 2022)
133 (107 - 162) 1992 Modelled IHME, GBD 2019 (accessed 2022)
128 (102 - 155) 1990 Modelled IHME, GBD 2019 (accessed 2022)
133 (106 - 161) 1993 Modelled IHME, GBD 2019 (accessed 2022)
132 (105 - 160) 1994 Modelled IHME, GBD 2019 (accessed 2022)
131 (104 - 160) 1995 Modelled IHME, GBD 2019 (accessed 2022)
130 (104 - 161) 1996 Modelled IHME, GBD 2019 (accessed 2022)
135 (108 - 165) 1998 Modelled IHME, GBD 2019 (accessed 2022)
132 (105 - 160) 1997 Modelled IHME, GBD 2019 (accessed 2022)
137 (109 - 167) 1999 Modelled IHME, GBD 2019 (accessed 2022)
139 (112 - 171) 2000 Modelled IHME, GBD 2019 (accessed 2022)
141 (113 - 173) 2001 Modelled IHME, GBD 2019 (accessed 2022)
145 (117 - 177) 2002 Modelled IHME, GBD 2019 (accessed 2022)
153 (121 - 188) 2004 Modelled IHME, GBD 2019 (accessed 2022)
150 (120 - 183) 2003 Modelled IHME, GBD 2019 (accessed 2022)
165 (130 - 204) 2005 Modelled IHME, GBD 2019 (accessed 2022)
175 (138 - 216) 2006 Modelled IHME, GBD 2019 (accessed 2022)
182 (143 - 226) 2007 Modelled IHME, GBD 2019 (accessed 2022)
187 (147 - 232) 2008 Modelled IHME, GBD 2019 (accessed 2022)
193 (150 - 239) 2009 Modelled IHME, GBD 2019 (accessed 2022)
203 (161 - 252) 2011 Modelled IHME, GBD 2019 (accessed 2022)
197 (155 - 245) 2010 Modelled IHME, GBD 2019 (accessed 2022)
206 (162 - 256) 2012 Modelled IHME, GBD 2019 (accessed 2022)
204 (162 - 253) 2013 Modelled IHME, GBD 2019 (accessed 2022)
202 (160 - 250) 2014 Modelled IHME, GBD 2019 (accessed 2022)
199 (158 - 250) 2015 Modelled IHME, GBD 2019 (accessed 2022)
197 (155 - 246) 2016 Modelled IHME, GBD 2019 (accessed 2022)
196 (150 - 249) 2018 Modelled IHME, GBD 2019 (accessed 2022)
197 (152 - 248) 2017 Modelled IHME, GBD 2019 (accessed 2022)
196 (149 - 249) 2019 Modelled IHME, GBD 2019 (accessed 2022)
40 (31 - 49) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Coverage of HepB birth dose

Newborns
Download
Value (%) Year Type Source
99 2019 Survey/reported WHO/UNICEF
99 2018 Survey/reported WHO/UNICEF
99 2017 Survey/reported WHO/UNICEF
99 2021 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
97 2019 Survey/reported WHO/UNICEF
97 2021 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
24 2017 Survey/reported Thailand Ending AIDS, 2015; Aramrattana A, 2017
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
21 2016 Survey/reported Larney et al, 2017
HBV elimination goal
HBV National Action Plan
HepB birth dose policy
Yes
Source: WHO
Year of birth dose introduction
1998
Source: WHO
Eligible for HBV generic medicines
Source: MPP
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
Source: MPP
At least one needle-syringe exchange program (NSP) operational
Yes
Source: Harm Reduction International
At least one opioid substitution therapy (OST) program operational
Yes
Source: Harm Reduction International
NSP in at least one prison
No
Source: Harm Reduction International
OST in at least one prison
No
Source: Harm Reduction International

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
0.39 2014 Modelled Wasitthankasem et al, 2016
1 2004 Modelled Wasitthankasem et al, 2016
0.7 (0.40 - 0.70) 2015 Modelled Blach et al, 2017
1.23 (1.01 - 1.48) 2019 Modelled IHME, GBD 2019 (accessed 2022)
1.23 (1 - 1.49) 2018 Modelled IHME, GBD 2019 (accessed 2022)
1.23 (1.01 - 1.49) 2017 Modelled IHME, GBD 2019 (accessed 2022)
1.23 (1.01 - 1.49) 2016 Modelled IHME, GBD 2019 (accessed 2022)
1.23 (1.01 - 1.50) 2015 Modelled IHME, GBD 2019 (accessed 2022)
1.24 (1.02 - 1.50) 2014 Modelled IHME, GBD 2019 (accessed 2022)
1.27 (1.04 - 1.53) 2013 Modelled IHME, GBD 2019 (accessed 2022)
1.3 (1.07 - 1.55) 2012 Modelled IHME, GBD 2019 (accessed 2022)
1.32 (1.09 - 1.58) 2011 Modelled IHME, GBD 2019 (accessed 2022)
1.32 (1.09 - 1.58) 2010 Modelled IHME, GBD 2019 (accessed 2022)
1.3 (1.07 - 1.55) 2009 Modelled IHME, GBD 2019 (accessed 2022)
1.25 (1.04 - 1.49) 2008 Modelled IHME, GBD 2019 (accessed 2022)
1.2 (1 - 1.42) 2007 Modelled IHME, GBD 2019 (accessed 2022)
1.16 (0.97 - 1.37) 2006 Modelled IHME, GBD 2019 (accessed 2022)
1.14 (0.95 - 1.34) 2005 Modelled IHME, GBD 2019 (accessed 2022)
1.15 (0.96 - 1.36) 2004 Modelled IHME, GBD 2019 (accessed 2022)
1.19 (0.99 - 1.40) 2003 Modelled IHME, GBD 2019 (accessed 2022)
1.23 (1.04 - 1.45) 2002 Modelled IHME, GBD 2019 (accessed 2022)
1.28 (1.07 - 1.50) 2001 Modelled IHME, GBD 2019 (accessed 2022)
1.29 (1.08 - 1.53) 2000 Modelled IHME, GBD 2019 (accessed 2022)
1.29 (1.09 - 1.52) 1999 Modelled IHME, GBD 2019 (accessed 2022)
1.29 (1.08 - 1.52) 1998 Modelled IHME, GBD 2019 (accessed 2022)
1.29 (1.08 - 1.52) 1997 Modelled IHME, GBD 2019 (accessed 2022)
1.28 (1.08 - 1.51) 1996 Modelled IHME, GBD 2019 (accessed 2022)
1.29 (1.08 - 1.52) 1995 Modelled IHME, GBD 2019 (accessed 2022)
1.31 (1.09 - 1.55) 1994 Modelled IHME, GBD 2019 (accessed 2022)
1.35 (1.12 - 1.61) 1993 Modelled IHME, GBD 2019 (accessed 2022)
1.42 (1.16 - 1.70) 1992 Modelled IHME, GBD 2019 (accessed 2022)
1.5 (1.21 - 1.81) 1991 Modelled IHME, GBD 2019 (accessed 2022)
1.59 (1.26 - 1.94) 1990 Modelled IHME, GBD 2019 (accessed 2022)
1.18 (0.97 - 1.42) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Women of childbearing age (15–49 years)
Download
Value (%) Year Type Source
0.35 (0.19 - 0.37) 2019 Modelled Dugan et al., 2021
Technical notes

Prevalence of anti-HCV

National
Download
Value (%) Year Type Source
0.94 2014 Modelled Wasitthankasem et al, 2016
2.15 2004 Modelled Wasitthankasem et al, 2016
0.94 2019 Modelled Jin et al. 2017
2.7 (1.80 - 3.70) 2014 Modelled Gower et al, 2014
Showing out of
Show more
Men who have sex with men (MSM) Living with HIV
Download
Value (%) Year Type Source
1.8 (0.80 - 3.30) 2019 Modelled Jin et al. 2017
People who inject drugs (PWID)
Download
Value (%) Year Type Source
88.5 (82.60 - 92.90) 2005 Survey/reported Luksamijarulkul P et al, 2009
Men who have sex with men (MSM)
Download
Value (%) Year Type Source
4.7 2019 Modelled Jin et al. 2017
Technical notes

Number of people living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
463,000 (255,000 - 487,000) 2015 Modelled Blach et al, 2017
879,700 (696,329 - 1,077,610) 1990 Modelled IHME, GBD 2019 (accessed 2022)
842,550 (676,930 - 1,015,180) 1991 Modelled IHME, GBD 2019 (accessed 2022)
807,386 (659,588 - 965,984) 1992 Modelled IHME, GBD 2019 (accessed 2022)
777,910 (641,361 - 928,381) 1993 Modelled IHME, GBD 2019 (accessed 2022)
758,424 (632,540 - 899,573) 1994 Modelled IHME, GBD 2019 (accessed 2022)
753,561 (632,044 - 891,942) 1995 Modelled IHME, GBD 2019 (accessed 2022)
758,819 (639,243 - 895,260) 1996 Modelled IHME, GBD 2019 (accessed 2022)
765,877 (645,634 - 904,433) 1997 Modelled IHME, GBD 2019 (accessed 2022)
773,590 (650,806 - 907,309) 1998 Modelled IHME, GBD 2019 (accessed 2022)
780,611 (655,227 - 917,567) 1999 Modelled IHME, GBD 2019 (accessed 2022)
785,747 (657,386 - 926,069) 2000 Modelled IHME, GBD 2019 (accessed 2022)
779,233 (654,944 - 912,975) 2001 Modelled IHME, GBD 2019 (accessed 2022)
758,280 (635,469 - 891,378) 2002 Modelled IHME, GBD 2019 (accessed 2022)
732,972 (613,552 - 866,024) 2003 Modelled IHME, GBD 2019 (accessed 2022)
713,877 (596,512 - 843,981) 2004 Modelled IHME, GBD 2019 (accessed 2022)
711,870 (594,181 - 841,444) 2005 Modelled IHME, GBD 2019 (accessed 2022)
740,468 (619,150 - 874,096) 2006 Modelled IHME, GBD 2019 (accessed 2022)
792,492 (662,120 - 938,061) 2007 Modelled IHME, GBD 2019 (accessed 2022)
834,170 (694,752 - 990,581) 2008 Modelled IHME, GBD 2019 (accessed 2022)
852,957 (705,139 - 1,015,650) 2009 Modelled IHME, GBD 2019 (accessed 2022)
865,332 (711,975 - 1,036,250) 2010 Modelled IHME, GBD 2019 (accessed 2022)
867,642 (716,237 - 1,037,460) 2011 Modelled IHME, GBD 2019 (accessed 2022)
858,167 (710,837 - 1,028,810) 2012 Modelled IHME, GBD 2019 (accessed 2022)
843,178 (693,505 - 1,021,040) 2013 Modelled IHME, GBD 2019 (accessed 2022)
830,027 (681,399 - 1,004,150) 2014 Modelled IHME, GBD 2019 (accessed 2022)
826,756 (678,710 - 1,008,630) 2015 Modelled IHME, GBD 2019 (accessed 2022)
829,523 (678,933 - 1,006,490) 2016 Modelled IHME, GBD 2019 (accessed 2022)
832,473 (681,468 - 1,012,590) 2017 Modelled IHME, GBD 2019 (accessed 2022)
835,516 (683,269 - 1,008,920) 2018 Modelled IHME, GBD 2019 (accessed 2022)
836,886 (687,441 - 1,005,310) 2019 Modelled IHME, GBD 2019 (accessed 2022)
829,190 (679,769 - 998,019) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Women of childbearing age (15–49 years)
Download
Value Year Type Source
61,500 (33,800 - 64,700) 2019 Modelled Dugan et al., 2021

HCV-related death rate

National
Download
Value (Deaths per 100,000) Year Type Source
13.6 (9.45 - 18.70) 2019 Modelled IHME, GBD 2019 (accessed 2020)
6.74 (5.23 - 8.45) 1990 Modelled IHME, GBD 2019 (accessed 2022)
6.89 (5.41 - 8.54) 1991 Modelled IHME, GBD 2019 (accessed 2022)
6.97 (5.50 - 8.61) 1992 Modelled IHME, GBD 2019 (accessed 2022)
7.06 (5.60 - 8.73) 1993 Modelled IHME, GBD 2019 (accessed 2022)
7.19 (5.70 - 8.94) 1994 Modelled IHME, GBD 2019 (accessed 2022)
7.33 (5.80 - 9.04) 1995 Modelled IHME, GBD 2019 (accessed 2022)
7.48 (5.88 - 9.37) 1996 Modelled IHME, GBD 2019 (accessed 2022)
7.3 (5.46 - 9.37) 1998 Modelled IHME, GBD 2019 (accessed 2022)
7.12 (5.39 - 9.06) 1997 Modelled IHME, GBD 2019 (accessed 2022)
7.86 (6.07 - 9.99) 1999 Modelled IHME, GBD 2019 (accessed 2022)
8.06 (6.21 - 10.08) 2000 Modelled IHME, GBD 2019 (accessed 2022)
7.99 (6.06 - 10.12) 2001 Modelled IHME, GBD 2019 (accessed 2022)
8.4 (6.53 - 10.42) 2002 Modelled IHME, GBD 2019 (accessed 2022)
9.04 (7.23 - 11.09) 2004 Modelled IHME, GBD 2019 (accessed 2022)
8.74 (6.95 - 10.65) 2003 Modelled IHME, GBD 2019 (accessed 2022)
9.58 (7.54 - 11.88) 2006 Modelled IHME, GBD 2019 (accessed 2022)
9.3 (7.35 - 11.58) 2005 Modelled IHME, GBD 2019 (accessed 2022)
9.7 (7.68 - 11.89) 2007 Modelled IHME, GBD 2019 (accessed 2022)
10.01 (7.97 - 12.34) 2008 Modelled IHME, GBD 2019 (accessed 2022)
11.09 (8.78 - 13.96) 2010 Modelled IHME, GBD 2019 (accessed 2022)
10.51 (8.31 - 13.04) 2009 Modelled IHME, GBD 2019 (accessed 2022)
11.42 (8.94 - 14.25) 2011 Modelled IHME, GBD 2019 (accessed 2022)
11.69 (9.16 - 14.65) 2012 Modelled IHME, GBD 2019 (accessed 2022)
11.86 (9.26 - 14.93) 2013 Modelled IHME, GBD 2019 (accessed 2022)
12.17 (9.41 - 15.43) 2014 Modelled IHME, GBD 2019 (accessed 2022)
12.46 (9.69 - 15.64) 2015 Modelled IHME, GBD 2019 (accessed 2022)
12.88 (10.02 - 16.42) 2016 Modelled IHME, GBD 2019 (accessed 2022)
13.11 (9.58 - 17.32) 2017 Modelled IHME, GBD 2019 (accessed 2022)
13.35 (9.53 - 18.21) 2018 Modelled IHME, GBD 2019 (accessed 2022)
13.58 (9.45 - 18.69) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
3,960 2016 Modelled WHO
9,521 (6,625 - 13,105) 2019 Modelled IHME, GBD 2019 (accessed 2022)
9,521 (6,625 - 13,105) 2019 Modelled IHME, GBD 2019 (accessed 2020)
9,342 (6,672 - 12,744) 2018 Modelled IHME, GBD 2019 (accessed 2022)
9,156 (6,688 - 12,090) 2017 Modelled IHME, GBD 2019 (accessed 2022)
8,969 (6,976 - 11,433) 2016 Modelled IHME, GBD 2019 (accessed 2022)
8,648 (6,723 - 10,850) 2015 Modelled IHME, GBD 2019 (accessed 2022)
8,410 (6,502 - 10,660) 2014 Modelled IHME, GBD 2019 (accessed 2022)
8,163 (6,372 - 10,273) 2013 Modelled IHME, GBD 2019 (accessed 2022)
8,004 (6,275 - 10,032) 2012 Modelled IHME, GBD 2019 (accessed 2022)
7,777 (6,084 - 9,702) 2011 Modelled IHME, GBD 2019 (accessed 2022)
7,508 (5,939 - 9,444) 2010 Modelled IHME, GBD 2019 (accessed 2022)
7,148 (5,653 - 8,872) 2009 Modelled IHME, GBD 2019 (accessed 2022)
6,920 (5,511 - 8,526) 2008 Modelled IHME, GBD 2019 (accessed 2022)
6,644 (5,258 - 8,147) 2007 Modelled IHME, GBD 2019 (accessed 2022)
6,347 (5,000 - 7,875) 2006 Modelled IHME, GBD 2019 (accessed 2022)
6,038 (4,775 - 7,523) 2005 Modelled IHME, GBD 2019 (accessed 2022)
5,834 (4,666 - 7,151) 2004 Modelled IHME, GBD 2019 (accessed 2022)
5,596 (4,452 - 6,819) 2003 Modelled IHME, GBD 2019 (accessed 2022)
5,341 (4,153 - 6,630) 2002 Modelled IHME, GBD 2019 (accessed 2022)
5,043 (3,826 - 6,388) 2001 Modelled IHME, GBD 2019 (accessed 2022)
5,051 (3,893 - 6,323) 2000 Modelled IHME, GBD 2019 (accessed 2022)
4,897 (3,778 - 6,218) 1999 Modelled IHME, GBD 2019 (accessed 2022)
4,514 (3,373 - 5,796) 1998 Modelled IHME, GBD 2019 (accessed 2022)
4,370 (3,308 - 5,557) 1997 Modelled IHME, GBD 2019 (accessed 2022)
4,554 (3,576 - 5,700) 1996 Modelled IHME, GBD 2019 (accessed 2022)
4,417 (3,497 - 5,452) 1995 Modelled IHME, GBD 2019 (accessed 2022)
4,295 (3,401 - 5,339) 1994 Modelled IHME, GBD 2019 (accessed 2022)
4,171 (3,307 - 5,154) 1993 Modelled IHME, GBD 2019 (accessed 2022)
4,072 (3,209 - 5,026) 1992 Modelled IHME, GBD 2019 (accessed 2022)
3,974 (3,118 - 4,921) 1991 Modelled IHME, GBD 2019 (accessed 2022)
3,832 (2,975 - 4,805) 1990 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
43 (30 - 59) 1991 Modelled IHME, GBD 2019 (accessed 2022)
43 (30 - 59) 1992 Modelled IHME, GBD 2019 (accessed 2022)
43 (30 - 58) 1990 Modelled IHME, GBD 2019 (accessed 2022)
42 (29 - 58) 1993 Modelled IHME, GBD 2019 (accessed 2022)
42 (28 - 57) 1994 Modelled IHME, GBD 2019 (accessed 2022)
41 (28 - 56) 1995 Modelled IHME, GBD 2019 (accessed 2022)
43 (29 - 57) 1997 Modelled IHME, GBD 2019 (accessed 2022)
41 (28 - 56) 1996 Modelled IHME, GBD 2019 (accessed 2022)
43 (30 - 58) 1998 Modelled IHME, GBD 2019 (accessed 2022)
44 (31 - 59) 1999 Modelled IHME, GBD 2019 (accessed 2022)
46 (32 - 61) 2000 Modelled IHME, GBD 2019 (accessed 2022)
47 (33 - 63) 2001 Modelled IHME, GBD 2019 (accessed 2022)
55 (38 - 73) 2004 Modelled IHME, GBD 2019 (accessed 2022)
49 (35 - 65) 2002 Modelled IHME, GBD 2019 (accessed 2022)
51 (36 - 68) 2003 Modelled IHME, GBD 2019 (accessed 2022)
61 (43 - 81) 2005 Modelled IHME, GBD 2019 (accessed 2022)
65 (46 - 87) 2006 Modelled IHME, GBD 2019 (accessed 2022)
69 (49 - 93) 2007 Modelled IHME, GBD 2019 (accessed 2022)
73 (51 - 97) 2008 Modelled IHME, GBD 2019 (accessed 2022)
77 (54 - 102) 2009 Modelled IHME, GBD 2019 (accessed 2022)
80 (56 - 107) 2010 Modelled IHME, GBD 2019 (accessed 2022)
83 (58 - 110) 2011 Modelled IHME, GBD 2019 (accessed 2022)
85 (60 - 112) 2012 Modelled IHME, GBD 2019 (accessed 2022)
86 (60 - 113) 2013 Modelled IHME, GBD 2019 (accessed 2022)
85 (59 - 113) 2014 Modelled IHME, GBD 2019 (accessed 2022)
85 (58 - 113) 2015 Modelled IHME, GBD 2019 (accessed 2022)
85 (58 - 112) 2016 Modelled IHME, GBD 2019 (accessed 2022)
85 (58 - 113) 2017 Modelled IHME, GBD 2019 (accessed 2022)
86 (60 - 115) 2018 Modelled IHME, GBD 2019 (accessed 2022)
87 (60 - 116) 2019 Modelled IHME, GBD 2019 (accessed 2022)
18 (12 - 23) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
24 2017 Survey/reported Thailand Ending AIDS, 2015; Aramrattana A, 2017
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
21 2016 Survey/reported Larney et al, 2017
HBV elimination goal
HBV National Action Plan
HepB birth dose policy
Yes
Source: WHO
Year of birth dose introduction
1998
Source: WHO
Eligible for HBV generic medicines
Source: MPP
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
Source: MPP
At least one needle-syringe exchange program (NSP) operational
Yes
Source: Harm Reduction International
At least one opioid substitution therapy (OST) program operational
Yes
Source: Harm Reduction International
NSP in at least one prison
No
Source: Harm Reduction International
OST in at least one prison
No
Source: Harm Reduction International

Overview

HBV elimination goal
HCV elimination goal

Prevalence (national)

Modelled

HBV (HBsAg+)
5.08 (%)
2019
(4.72 - 5.45(%))
IHME, GBD 2019 (accessed 2022)
HCV (RNA/cAg+)
1.18 (%)
2019
(0.97 - 1.42(%))
IHME, GBD 2019 (accessed 2020)

Survey/surveillance

HBV (HBsAg+)
0.7 (%)
2006
Chongsrisawat V et al, 2006
No data available

Hepatitis related deaths (national)

Modelled

HBV
13,240
2019
(9,240 - 18,333)
IHME, GBD 2019 (accessed 2020)

Survey/surveillance

No data available
HBV chart

Modelled

HCV
9,521
2019
(6,625 - 13,105)
IHME, GBD 2019 (accessed 2022)

Survey/surveillance

No data available
HCV chart

Prevalence < 5

HBV
0.27 (%)
2020, latest modelled
(0.23 - 0.32(%))
WHO

Prevalence PWID

HCV
88.50 (%)
2005, survey/surveillance
(82.60 - 92.90(%))
Luksamijarulkul P et al, 2009

Birth dose vaccination coverage (national)

Survey/surveillance

HBV
99 (%)
2021
WHO/UNICEF

No. of syringes/PWID/year

Survey/surveillance

HCV
24
2017
(2 - 0)
Thailand Ending AIDS, 2015; Aramrattana A, 2017
Eligible for HBV generic medicines
Eligible for HCV generic medicines

Latest news

View all

News

Resources

Programs

Partners